Paclitaxel - analytical standard,≥99%, high purity , CAS No.33069-62-4, Agonist of Pregnane X receptor;Agonist of TLR4;Inhibitor of tubulin beta class I

62 Citations
Item Number
P106868
Grouped product items
SKUSizeAvailabilityPrice Qty
P106868-10mg
10mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$118.90

Anticancer agent

Basic Description

Synonyms33069-62-4 | P88XT4IS4D | Paclitaxel | Taxol | Taxol A | Yewtaxan | Genaxol | Plaxicel | Abraxane | Ebetaxel | Genetaxyl | Capxol | Cyclopax | Genexol | Intaxel | Mitotax | Paxene | Onxol | TaxAlbin | OncoGel | Pacliex | Paxceed | EmPAC | Onxal | Zisu | Taxus stent | Taxus Liberte | ABI-007 | Padexol | EndoTAG 1
Specifications & PurityMoligand™, analytical standard, ≥99%
Biochemical and Physiological MechanismsTaxol, an antineoplastic and antimicrotubule agent, posses mechanisms of cytotoxic action and has a broad antineoplastic spectrum compared to the vinca alkaloids. Studies have shown that Taxol is an inhibitor of neurite outgrowth and initiation by destroy
Storage TempStore at 2-8°C
Shipped InWet ice
Gradeanalytical standard, Moligand™
Action TypeAGONIST, INHIBITOR
Mechanism of actionAgonist of Pregnane X receptor;Agonist of TLR4;Inhibitor of tubulin beta class I
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Note: Some researchers have found solubility issues in PBS. The recommended procedure (from researcher feedback) for successful solubilisation is as follows: Solubilise 10 mg of ab120143 in 1.25 mL ethanol absolute, mix well, add 1.25mL Cremophor, homogenise. Store at -20°C and after 24 h, defreeze quickly and solubilise in PBS, no crystallisation observed. Please note, Abcam has not yet tested this method. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.
An antineoplastic and apoptosis inducing agent

Product Properties

ALogP2.5

Associated Targets(Human)

SLCO1B1 Tchem Solute carrier organic anion transporter family member 1B1 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TUBB3 Tclin Tubulin beta-3 chain (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TUBB Tclin Tubulin beta chain (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TLR4 Tchem Toll-like receptor 4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NR1I2 Tchem Nuclear receptor subfamily 1 group I member 2 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRHR1 Tclin Corticotropin releasing factor receptor 1 (2996 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 reverse transcriptase (18245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase AmpC (62480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cruzipain (33337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ntsr1 Neurotensin receptor 1 (48 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bdkrb1 Bradykinin B1 receptor (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcc1 Multidrug resistance-associated protein 1 (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ppard Peroxisome proliferator-activated receptor delta (358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1b P-glycoprotein 1 (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPN1 Calpain 1 (219 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB2B Tubulin beta chain (424 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1a P-glycoprotein 3 (492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBA1A Tubulin alpha chain (497 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HD1 Histone deacetylase (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
beta-tubulin Beta tubulin (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus mutans (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drosophila melanogaster (359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Artemia (698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sus scrofa (849 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oryctolagus cuniculus (11301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Parastagonospora nodorum (325 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania sp. (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Botrytis cinerea (4183 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A10 (235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF S-180 (1031 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
INCHI InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1
InChi Key RCINICONZNJXQF-MZXODVADSA-N
Canonical SMILES CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
Isomeric SMILES CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
WGK Germany 3
RTECS DA8340700
PubChem CID 36314
UN Number 2811
Packing Group I
Molecular Weight 853.91
Beilstein 1420457

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot NumberCertificate TypeDateItem
J2126748Certificate of AnalysisAug 16, 2023 P106868
B2327845Certificate of AnalysisMar 11, 2023 P106868
H2202414Certificate of AnalysisFeb 09, 2023 P106868
D2123071Certificate of AnalysisJan 17, 2023 P106868

Chemical and Physical Properties

Specific Rotation[α]-49 ° (C=1, MeOH)
Melt Point(°C)213-216°C

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS05,   GHS07
Signal Danger
Hazard Statements

H315:Causes skin irritation

H335:May cause respiratory irritation

H341:Suspected of causing genetic defects

H413:May cause long lasting harmful effects to aquatic life

H318:Causes serious eye damage

H317:May cause an allergic skin reaction

H334:May cause allergy or asthma symptoms or breathing difficulties if inhaled

H372:Causes damage to organs through prolonged or repeated exposure

H360:May damage fertility or the unborn child

H340:May cause genetic defects

H361:Suspected of damaging fertility or the unborn child

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P284:[In case of inadequate ventilation] Wear respiratory protection.

P281:Use personal protective equipment as required.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P272:Contaminated work clothing should not be allowed out of the workplace.

P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention.

P362+P364:Take off contaminated clothing and wash it before reuse.

P203:Obtain, read and follow all safety instructions before use.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P305+P354+P338:IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing.

P318:if exposed or concerned, get medical advice.

P317:Get emergency medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

P342+P316:If experiencing respiratory symptoms: Get emergence medical help immediately.

WGK Germany 3
RTECS DA8340700
Class 6.1
Merck Index 6982

Related Documents

Citations of This Product

1. Meijia Zheng, Chenxi Zhou, Hong Liao, Qin Li, Alan Bao, Chunmei Chen, Feng He, Peng Wu, Weiguang Sun, Hucheng Zhu, Yonghui Zhang.  (2024)  Enantiomeric α-pyrone derivatives with immunosuppressive activity from Talaromyces adpressus.  PHYTOCHEMISTRY,  218  (15): (113931).  [PMID:38029950]
2. Li Qiwei, Chen Zaozao, Zhang Ying, Ding Shuang, Ding Haibo, Wang Luping, Xie Zhuoying, Fu Yifu, Wei Mengxiao, Liu Shengnan, Chen Jialun, Wang Xuan, Gu Zhongze.  (2023)  Imaging cellular forces with photonic crystals.  Nature Communications,  14  (1): (1-14).  [PMID:37963911]
3. Fang Chen, Li Yin, Teng He, Tao Chen, Hangbo Yue, Chufen Yang.  (2023)  Fabrication of Dual pH/Reduction-Responsive P(CL-co-ACL)-Based Cross-Linked Polymeric Micelles for PTX Delivery.  LANGMUIR,  39  (46): (16358–16366).  [PMID:37934563]
4. Yiqian Zhang, Qianrui Huang, Qisi Xu, Chengsen Jia, Yong Xia.  (2023)  Pimavanserin tartrate induces apoptosis and cytoprotective autophagy and synergizes with chemotherapy on triple negative breast cancer.  BIOMEDICINE & PHARMACOTHERAPY,  168  (8): (115665).  [PMID:37832400]
5. Chaoyao Geng, Jiaqi Niu, Dan Zhao, Xiaoxin Jin, Jiaojiao Liu, Xiaoqiang Liu, Danny K.Y. Wong.  (2023)  Evaluation of electrocatalysis of hourglass-shaped polyoxometallates with different transition metals towards hydrogen peroxide transformed from superoxide radicals in living cell mitochondria.  CHEMICAL ENGINEERING JOURNAL,  475  (7): (146302).  [PMID:21211617]
6. Hao Wei, Yongxiang Luo, Ruisen Ma, Yuxiao Li.  (2023)  Three-Dimensional Printing Multi-Drug Delivery Core/Shell Fiber Systems with Designed Release Capability.  Pharmaceutics,  15  (9): (2336).  [PMID:37765304]
7. Xinping Hu, Chuhang Zhou, Leqi Wang, Qi Liu, Yining Ma, Yingwei Tang, Xiaoxiao Wang, Kanghao Chen, Xinyu Wang, Yan Liu.  (2023)  Procedurally Targeted Delivery of Antitumor Drugs Using FAPα-Responsive TPGS Dimer-Based Flower-like Polymeric Micelles.  ACS Applied Bio Materials,      [PMID:37702706]
8. Qi Nie, Wenqing Chen, Tianmei Zhang, Shangrong Ye, Zhongyu Ren, Peng Zhang, Jian Wen.  (2023)  Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel.  Molecular Medicine Reports,  28  (4): (1-13).  [PMID:37681444]
9. Hong Shen, Changwei Zhang, Chengzhang Wang, Jianxin Jiang, Fengxia Tang, Chuan Li, Hua Yuan, Xiaoran Yang, Zhenkai Tong, Yi Huang.  (2023)  Lutein-Based pH and Photo Dual-Responsive Novel Liposomes Coated with Ce6 and PTX for Tumor Therapy.  ACS Omega,  (34): (31436–31449).  [PMID:37663483]
10. Yao Liu, Zhichao He, Heng Liang, Minzhen Han, Jinxingyi Wang, Qian Liu, Yanping Guan.  (2023)  A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma.  ANALYTICAL BIOCHEMISTRY,  676  (115230).  [PMID:37429484]
11. Fenglin Huang, Sisi Yang, Hao Wang, Peiwen Zhao, Bo Zhou, Bo Cheng, Siyan Dong, Jing Yang, Binbin Li, Xinyu Wang.  (2023)  pH-responsive PLGA/gelatin porous microspheres containing paclitaxel used for inhibition of cancer cell proliferation.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  86  (104735).  [PMID:]
12. Heming Zhao, Liming Gong, Hao Wu, Chao Liu, Yanhong Liu, Congcong Xiao, Chenfei Liu, Liqing Chen, Mingji Jin, Zhonggao Gao, Youyan Guan, Wei Huang.  (2023)  Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells.  Pharmaceutics,  15  (7): (1874).  [PMID:37514059]
13. Shuncheng Yao, Shaobo Wang, Minjia Zheng, Zhuo Wang, Zhirong Liu, Zhong Lin Wang, Linlin Li.  (2023)  Implantable, Biodegradable, and Wireless Triboelectric Devices for Cancer Therapy Through Disrupting Microtubule and Actins Dynamics.  ADVANCED MATERIALS,    (2303962).  [PMID:37392034]
14. Deqian Qiao, Yiling Liu, Yunlong Lei, Chundong Zhang, Youquan Bu, Yishu Tang, Ying Zhang.  (2023)  rRNA-Derived Small RNA rsRNA-28S Regulates the Chemoresistance of Prostate Cancer Cells by Targeting PTGIS.  Frontiers in Bioscience-Landmark,  28  (5): (102).  [PMID:37258478]
15. Qi Wenxia, Wang Shenglan, Yang Heng, Luo Tingting, Zhao Feng, Han Jingtian, Zhang Jing.  (2023)  An albumin-based nanosystem for cocktail therapy of breast cancer amplifies the therapeutic efficacy of combination chemotherapy with photodynamic therapy.  JOURNAL OF MATERIALS SCIENCE,  58  (21): (8952-8968).  [PMID:]
16. Xinran Wang, Jieyi Pan, Haohui Shi, Na Liang, Shaoping Sun.  (2023)  Biotin-modified acid-sensitive micelles for enhancing antitumor effect of paclitaxel.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  84  (104538).  [PMID:]
17. Pingfu Huang, Hui Yan, Hao Wu, Lulu Liu, Wenmin Niu, Bo Zhai, Ziwei Hu, Jingjuan Li, Qianming Du, Yang Zhou.  (2023)  Application of curcumin as a co-former and an efflux inhibitor in paclitaxel co-amorphous mixture.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  84  (104513).  [PMID:]
18. Feng Gao, Xinmin Zhao, Qiankang Si, Xingkun Niu, Shaojie Hou, Shihao Liu, Jun Guo, Liping Wang, Feng Zhang.  (2023)  Gemini surfactant-like peptide-based nanocages with β-sheet-enhanced stability and encapsulation efficiency of hydrophobic anticancer drugs.  RSC Advances,  13  (19): (12863-12868).  [PMID:37114030]
19. Changhai Wang, Yuwen Jiao, Xinyu Zhang, Mingxue Guo, Qing Zhang, Wenjun Hu, Shuang Dong, Tangthianchaichana Jakkree, Yang Lu, Jinling Wang.  (2023)  A paclitaxel prodrug nanoparticles with glutathion/reactive oxygen species dual-responsive and CD206 targeting to improve the anti-tumour effect.  IET Nanobiotechnology,  17  (5): (406-419).  [PMID:37055350]
20. Chunjing Guo, Wei Zhang, Qiaoyun Zhang, Yanguo Su, Xiaoya Hou, Qiang Chen, Huimin Guo, Ming Kong, Daquan Chen.  (2023)  Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer.  Artificial Cells Nanomedicine and Biotechnology,  51  (1): (170-179).  [PMID:37014123]
21. Jingshuai Wang, Xuemin Gu, Yiqin Ouyang, Lei Chu, Mengjiao Xu, Kun Wang, Xiaowen Tong.  (2023)  Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor Therapy.  International Journal of Nanomedicine,      [PMID:33623381]
22. Yaqin Tu, Wei Zhang, Guorun Fan, Chenming Zou, Jie Zhang, Nan Wu, Jiahui Ding, Wen Qing Zou, Hongjun Xiao, Songwei Tan.  (2023)  Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy.  DRUG DELIVERY,  30  (1): (2189106).  [PMID:36916054]
23. Zhou LiPing, Li JiaWei, Yu Bing, Zhang Jun, Hu Hao, Cong HaiLin, Shen YouQing.  (2023)  The drug loading behavior of PAMAM dendrimer: Insights from experimental and simulation study.  Science China-Technological Sciences,  66  (4): (1129-1140).  [PMID:]
24. Asmaa S.A. Hammad, Mohamed M. Sayed-Ahmed, Sara Mohamed Naguib Abdel Hafez, Ahmed R.N. Ibrahim, Mohamed M.A. Khalifa, Mahmoud El-Daly.  (2023)  Trimetazidine alleviates paclitaxel-induced peripheral neuropathy through modulation of TLR4/p38/NF-κB and klotho protein expression.  CHEMICO-BIOLOGICAL INTERACTIONS,  376  (110446).  [PMID:36898573]
25. Liu Fei, Xu Yanjun, Wang Li, Ma Xifeng, Zhang Zhen, Zhuang Xiaomei.  (2023)  Combined contributions of cytochrome P450s (CYPs) and non-enzymatic metabolism in the in vitro biotransformation of anaprazole, a novel proton pump inhibitor.  NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY,  396  (8): (1759-1771).  [PMID:36847804]
26. Yanzhao Jin, Jiaqing Cao, Hua Cheng, Xiaoyun Hu.  (2023)  LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.  JOURNAL OF CHEMOTHERAPY,      [PMID:36797828]
27. Wenquan Huang, Zhiqiang Li, Weiqi Liu, Shiyuan Liu, Rujin Zhou, Yanbin Jiang.  (2023)  Preparation of B16 cancer cell membrane coated α-zein biomimetic drug delivery system for the enhancement of homotypic target ability.  INDUSTRIAL CROPS AND PRODUCTS,  194  (116301).  [PMID:]
28. Chen Cheng, Weixi Jiang, Yuanli Luo, Li Wan, Xun Guo, Zhuoyan Xie, Rui Tang, Tong Huang, Jingxue Wang, Chier Du, Zhigang Wang, Haitao Ran, Pan Li, Zhiyi Zhou, Jianli Ren.  (2023)  NIR Activated Multimodal Therapeutics Based on Metal–Phenolic Networks-Functionalized Nanoplatform for Combating against Multidrug Resistance and Metastasis.  Small,  19  (14): (2206174).  [PMID:36651135]
29. Liang Chen, Yi Xu.  (2023)  Low temperature upregulating HSP70 expression to mitigate the paclitaxel-induced damages in NHEK cell.  PeerJ,  11  (e14630).  [PMID:36684674]
30. Xun Guo, Peng Tu, Leilei Zhu, Chen Cheng, Weixi Jiang, Chier Du, Xiaoting Wang, Xiaoling Qiu, Yuanli Luo, Li Wan, Rui Tang, Haitao Ran, Zhigang Wang, Jianli Ren.  (2023)  Nanoenabled Tumor Energy Metabolism Disorder via Sonodynamic Therapy for Multidrug Resistance Reversal and Metastasis Inhibition.  ACS Applied Materials & Interfaces,  15  (1): (309–326).  [PMID:36576435]
31. Li Huang, Huaqiang Fang, Teng Zhang, Binbin Hu, Shichen Liu, Fanzhen Lv, Zhaoxia Zeng, Huijie Liu, Weimin Zhou, Xiaolei Wang.  (2023)  Drug-loaded balloon with built-in NIR controlled tip-separable microneedles for long-effective arteriosclerosis treatment.  Bioactive Materials,  23  (526).  [PMID:36514389]
32. Lianzhen Li, Ziqiang Shang, Jianfu Tang, Jiameng Li, Zefang Xiao, Yanjun Xie, Jiuqing Liu, Zhenjie Li, Shilong Yang, Yiqi Liu, Wentao Gan.  (2022)  Wood Robot with Magnetic Anisotropy for Programmable Locomotion.  ADVANCED FUNCTIONAL MATERIALS,  33  (6): (2207209).  [PMID:]
33. Tong Gao, Xiao Sang, Xinyan Huang, Panpan Gu, Jie Liu, Yongjun Liu, Na Zhang.  (2022)  Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer.  Acta Pharmaceutica Sinica B,      [PMID:37799382]
34. Hong Liu, Zhenfu Wen, Haolin Chen, Zeyu Yang, Zhicheng Le, Zhijia Liu, Yongming Chen, Lixin Liu.  (2022)  Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels.  JOURNAL OF CONTROLLED RELEASE,  352  (497).  [PMID:36341931]
35. Jiayin Liu, Yang An, Jun Su, Qinghai Dong, Hongliu Xie, Jihua Liu.  (2022)  The antitumor activity and pharmacokinetics research of PPD-Arg (Tos) using ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.  BIOMEDICAL CHROMATOGRAPHY,  37  (2): (e5535).  [PMID:36289571]
36. ChengYu Deng, Rong Zhuang, ZhuoYang Ying, Jiasheng Tu, Xianghui Xu, Chunmeng Sun, Lei Jiang.  (2022)  Non-Invasive Transdermal Delivery Systems with Deep Tissue Penetrating Ability for Local ROS-Modulating Chemotherapy.  ADVANCED FUNCTIONAL MATERIALS,  32  (46): (2206876).  [PMID:]
37. Xueting Tang, Lin Chen, Ziyu Wu, Yazhou Li, Jiaqi Zeng, Wentao Jiang, Wenzhi Lv, Mimi Wan, Chun Mao, Min Zhou.  (2022)  Lipophilic NO-Driven Nanomotors as Drug Balloon Coating for the Treatment of Atherosclerosis.  Small,  19  (13): (2203238).  [PMID:35961946]
38. Tianyu Chen, Hui Chen, Yichun Jiang, Qi Yan, Shuling Zheng, Min Wu.  (2022)  Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment.  Pharmaceuticals,  15  (7): (881).  [PMID:35890181]
39. Chunyan Yang, Zhongzhen Yang, Siqi Wang, Jinxia Chen, Qijun Liu, Tianle Huang, Li Hai, Runxin Lu, Yong Wu.  (2022)  Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.  BIOORGANIC & MEDICINAL CHEMISTRY,  69  (116893).  [PMID:35752143]
40. Chenglong Wang, Xiaolin Xu, Shuhan Xiong, Peipei Zhang, Jia Yuan, Xuzhu Gao, Wencai Guan, Fanchen Wang, Xin Li, Tao Leng, Hongjing Dou, Guoxiong Xu.  (2022)  Calcium-chelated nanosystem reversing cancer chemoresistance via replenishing intracellular calcium ions.  CHEMICAL ENGINEERING JOURNAL,  448  (137500).  [PMID:]
41. Xiaowei Wang, Yanhong Liu, Yue Hu, Hong Gao, Meiling Ge, Jie Ding, Dongkai Wang.  (2022)  Hybrid micelles loaded with chemotherapeutic drug-photothermal agent realizing chemo-photothermal synergistic cancer therapy.  EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,  175  (106231).  [PMID:35671901]
42. Yi Peng, Jie Pan, Fengting Ou, Wenchao Wang, Haihong Hu, Lu Chen, Su Zeng, Kui Zeng, Lushan Yu.  (2022)  Fenbendazole and its synthetic analog interfere with HeLa cells’ proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway.  CHEMICO-BIOLOGICAL INTERACTIONS,  361  (109983).  [PMID:35569513]
43. Xiao-Ling Wang, Wen-Zheng Zhao, Jia-Ze Fan, Le-Chen Jia, Ya-Nan Lu, Ling-Hui Zeng, Yuan-Yuan Lv, Xiao-Yi Sun.  (2022)  Tumor Tropic Delivery of Hyaluronic Acid-Poly (D,L-lactide-co-glycolide) Polymeric Micelles Using Mesenchymal Stem Cells for Glioma Therapy.  MOLECULES,  27  (8): (2419).  [PMID:35458619]
44. Mingming Song, Shuqi Dong, Xiaofei An, Wenxiang Zhang, Ning Shen, Yanbo Li, Caixia Guo, Chang Liu, Xiao Li, Siyu Chen.  (2022)  Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.  JOURNAL OF CONTROLLED RELEASE,  345  (744).  [PMID:35381274]
45. Yan Du, Li Lin, Zhong Zhang, Yu Tang, Xia Ou, Yaotai Wang, Jianzhong Zou.  (2022)  Drug-loaded nanoparticles conjugated with genetically engineered bacteria for cancer therapy.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  606  (29).  [PMID:35338856]
46. Huiru Zhu, Li Kong, Xu Zhu, Tingting Ran, Xiaojuan Ji.  (2022)  pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis.  Pharmaceutics,  14  (3): (535).  [PMID:35335910]
47. Beibei Zhang, Rui Xue, Chunyang Sun.  (2022)  Rational design of ROS-responsive nanocarriers for targeted X-ray-induced photodynamic therapy and cascaded chemotherapy of intracranial glioblastoma.  Nanoscale,  14  (13): (5054-5067).  [PMID:35293920]
48. Xinling Xie, Youquan Zhang, Yong Zhu, Yiling Lan.  (2022)  Preparation and Drug-Loading Properties of Amphoteric Cassava Starch Nanoparticles.  Nanomaterials,  12  (4): (598).  [PMID:35214927]
49. Chunjing Guo, Yanguo Su, Ziting Cheng, Qiang Chen, Huimin Guo, Ming Kong, Daquan Chen.  (2022)  Novel ROS-responsive marine biomaterial fucoidan nanocarriers with AIE effect and chemodynamic therapy.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,  202  (112).  [PMID:35041879]
50. Hao Li, Wenbo Xie, Lei Zeng, Wen Li, Boan Shi, Fuhou Lei.  (2022)  Development and evaluation of a hydrogenated rosin (β-acryloxyl ethyl) ester–bonded silica stationary phase for high-performance liquid chromatography separation of paclitaxel from yew bark.  JOURNAL OF CHROMATOGRAPHY A,  1665  (462815).  [PMID:35038614]
51. Yangming-Fan, Jianjun-Ge.  (2022)  Pentoxifylline Prevents Restenosis by Inhibiting Cell Proliferation via p38MAPK Pathway in Rat Vein Graft Model..  CELL TRANSPLANTATION,  31  (9636897221122999-9636897221122999).  [PMID:36066039]
52. Haiqin Huang, Lanlan Shao, Yan Chen, Lan Tang, Tianqing Liu, Junxu Li, Hongyan Zhu.  (2021)  Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes−liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer.  Bioengineering & Translational Medicine,  (2): (e10284).  [PMID:35600651]
53. Sushan Ouyang, Yi Zhang, Sheng Yao, Longbao Feng, Ping Li, Senlin Zhu.  (2021)  The efficiency of MSC-based targeted AIE nanoparticles for gastric cancer diagnosis and treatment: An experimental study.  Bioengineering & Translational Medicine,  (2): (e10278).  [PMID:35600644]
54. Huan Zhang, Jinshun Xu, Binyang Gao, Hong Wang, Jianbo Huang, Jie Zhou, Rui Yang, Feng Yan, Yulan Peng.  (2021)  Synergistic Cascade Strategy Based on Modifying Tumor Microenvironment for Enhanced Breast Cancer Therapy.  Frontiers in Pharmacology,  12  (750847).  [PMID:34867360]
55. Yuqiong Shi, Wei Liu, Xiangrong Wu, Jinhua Zhu, Danyang Zhou, Xiuhua Liu.  (2021)  A Water-Soluble Polyacid Polymer Based on Hydrophilic Metal–Organic Frameworks Using Amphoteric Carboxylic Acid Ligands as Linkers for Hydroxycamptothecin Loading and Release In Vitro.  Nanomaterials,  11  (11): (2854).  [PMID:34835619]
56. Tian Chai, Yin Qiang.  (2022)  Two new coumarins from branches of Zanthoxylum schinifolium.  JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH,  24  (9): (820-826).  [PMID:34662216]
57. Rui Zhang, Ge Cheng, Shengnan Liu, Hongying Lv, Juan Li.  (2021)  A four-in-one pure nanomedicine for synergistic multi-target therapy against breast cancer.  Journal of Materials Chemistry B,  (42): (8809-8822).  [PMID:34633023]
58. Yadong Tang,Boxin Huang,Yuqin Dong,Wenlong Wang,Xi Zheng,Wei Zhou,Kun Zhang,Zhiyun Du.  (2017-06-07)  Three-dimensional prostate tumor model based on a hyaluronic acid-alginate hydrogel for evaluation of anti-cancer drug efficacy..  Journal of biomaterials science. Polymer edition,  28  ((14)): (1603-1616).  [PMID:28583017]
59. Lingling Wang,Xiuhua Zhao,Fengjian Yang,Weiwei Wu,Mingfang Wu,Yuanyuan Li,Xiaoxue Zhang.  (2019-07-16)  Loading paclitaxel into porous starch in the form of nanoparticles to improve its dissolution and bioavailability..  International journal of biological macromolecules,  138  (207-214).  [PMID:31306708]
60. Wanbing Qin,Guilan Quan,Ying Sun,Minglong Chen,Peipei Yang,Disang Feng,Ting Wen,Xinyu Hu,Xin Pan,Chuanbin Wu.  (2020-07-30)  Dissolving Microneedles with Spatiotemporally controlled pulsatile release Nanosystem for Synergistic Chemo-photothermal Therapy of Melanoma..  Theranostics,  10  ((18)): (8179-8196).  [PMID:32724465]
61. Xuejing Zhang,Shiwei Niu,Gareth R Williams,Jianrong Wu,Xia Chen,Hong Zheng,Li-Min Zhu.  (2019-06-23)  Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy..  Carbohydrate polymers,  221  (84-93).  [PMID:31227170]
62. Li FF, Sun Q, Wang D, Liu S, Lin B, Liu CT, Li LZ, Huang XX, Song SJ..  (2016)  Chiral Separation of Cytotoxic Flavan Derivatives from Daphne giraldii..  J Nat Prod,  79  (9): (2236-2242).  [PMID:27627130]

References

1. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M.  (2000)  Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol..  J Biol Chem,  275  (4): (2251-4).  [PMID:10644670]
2. Lee ST et al..  (2011)  Alpha-tomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells..  PLoS One,  (4): (e18915).  [PMID:21541327]
3. Wala K et al..  (2022)  Anticancer Efficacy of 6-Gingerol with Paclitaxel against Wild Type of Human Breast Adenocarcinoma..  Molecules,  27  (9):   [PMID:35566044]
4. Rose JC et al..  (2018)  Biofunctionalized aligned microgels provide 3D cell guidance to mimic complex tissue matrices..  Biomaterials,  163  (128-141).  [PMID:29459322]
5. Dong P et al..  (2013)  Induction of paclitaxel resistance by ERa mediated prohibitin mitochondrial-nuclear shuttling..  PLoS One,  (12): (e83519).  [PMID:24376711]
6. Liu M et al..  (2021)  Identification of a prognostic chemoresistance-related gene signature associated with immune microenvironment in breast cancer..  Bioengineered,  12  (8419-8434).  [PMID:34661511]
7. Lai SL et al..  (2012)  In vitro and in vivo anti-angiogenic activities of Panduratin A..  PLoS One,  (5): (e38103).  [PMID:22666456]
8. Ferreira SA et al..  (2018)  Neighboring cells override 3D hydrogel matrix cues to drive human MSC quiescence..  Biomaterials,  176  (13-23).  [PMID:29852376]
9. Samanta J et al..  (2020)  Oleic Acid Protects from Arsenic-Induced Cardiac Hypertrophy via AMPK/FoxO/NFATc3 Pathway..  Cardiovasc Toxicol,  20  (3): (261-280).  [PMID:31571030]
10. Yang Y et al..  (2016)  Skp2 is associated with paclitaxel resistance in prostate cancer cells..  Oncol Rep,  36  (559-66).  [PMID:27175797]
11. Tran LNK et al..  (2017)  The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer..  Mol Cancer Ther,  16  (12): (2689-2700).  [PMID:28802253]
12. Materazzi S et al..  (2012)  TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism..  Pflugers Arch,  463  (4): (561-9).  [PMID:22258694]
13. Meijia Zheng, Chenxi Zhou, Hong Liao, Qin Li, Alan Bao, Chunmei Chen, Feng He, Peng Wu, Weiguang Sun, Hucheng Zhu, Yonghui Zhang.  (2024)  Enantiomeric α-pyrone derivatives with immunosuppressive activity from Talaromyces adpressus.  PHYTOCHEMISTRY,  218  (15): (113931).  [PMID:38029950]
14. Li Qiwei, Chen Zaozao, Zhang Ying, Ding Shuang, Ding Haibo, Wang Luping, Xie Zhuoying, Fu Yifu, Wei Mengxiao, Liu Shengnan, Chen Jialun, Wang Xuan, Gu Zhongze.  (2023)  Imaging cellular forces with photonic crystals.  Nature Communications,  14  (1): (1-14).  [PMID:37963911]
15. Fang Chen, Li Yin, Teng He, Tao Chen, Hangbo Yue, Chufen Yang.  (2023)  Fabrication of Dual pH/Reduction-Responsive P(CL-co-ACL)-Based Cross-Linked Polymeric Micelles for PTX Delivery.  LANGMUIR,  39  (46): (16358–16366).  [PMID:37934563]
16. Yiqian Zhang, Qianrui Huang, Qisi Xu, Chengsen Jia, Yong Xia.  (2023)  Pimavanserin tartrate induces apoptosis and cytoprotective autophagy and synergizes with chemotherapy on triple negative breast cancer.  BIOMEDICINE & PHARMACOTHERAPY,  168  (8): (115665).  [PMID:37832400]
17. Chaoyao Geng, Jiaqi Niu, Dan Zhao, Xiaoxin Jin, Jiaojiao Liu, Xiaoqiang Liu, Danny K.Y. Wong.  (2023)  Evaluation of electrocatalysis of hourglass-shaped polyoxometallates with different transition metals towards hydrogen peroxide transformed from superoxide radicals in living cell mitochondria.  CHEMICAL ENGINEERING JOURNAL,  475  (7): (146302).  [PMID:21211617]
18. Hao Wei, Yongxiang Luo, Ruisen Ma, Yuxiao Li.  (2023)  Three-Dimensional Printing Multi-Drug Delivery Core/Shell Fiber Systems with Designed Release Capability.  Pharmaceutics,  15  (9): (2336).  [PMID:37765304]
19. Xinping Hu, Chuhang Zhou, Leqi Wang, Qi Liu, Yining Ma, Yingwei Tang, Xiaoxiao Wang, Kanghao Chen, Xinyu Wang, Yan Liu.  (2023)  Procedurally Targeted Delivery of Antitumor Drugs Using FAPα-Responsive TPGS Dimer-Based Flower-like Polymeric Micelles.  ACS Applied Bio Materials,      [PMID:37702706]
20. Qi Nie, Wenqing Chen, Tianmei Zhang, Shangrong Ye, Zhongyu Ren, Peng Zhang, Jian Wen.  (2023)  Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel.  Molecular Medicine Reports,  28  (4): (1-13).  [PMID:37681444]
21. Hong Shen, Changwei Zhang, Chengzhang Wang, Jianxin Jiang, Fengxia Tang, Chuan Li, Hua Yuan, Xiaoran Yang, Zhenkai Tong, Yi Huang.  (2023)  Lutein-Based pH and Photo Dual-Responsive Novel Liposomes Coated with Ce6 and PTX for Tumor Therapy.  ACS Omega,  (34): (31436–31449).  [PMID:37663483]
22. Yao Liu, Zhichao He, Heng Liang, Minzhen Han, Jinxingyi Wang, Qian Liu, Yanping Guan.  (2023)  A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma.  ANALYTICAL BIOCHEMISTRY,  676  (115230).  [PMID:37429484]
23. Fenglin Huang, Sisi Yang, Hao Wang, Peiwen Zhao, Bo Zhou, Bo Cheng, Siyan Dong, Jing Yang, Binbin Li, Xinyu Wang.  (2023)  pH-responsive PLGA/gelatin porous microspheres containing paclitaxel used for inhibition of cancer cell proliferation.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  86  (104735).  [PMID:]
24. Heming Zhao, Liming Gong, Hao Wu, Chao Liu, Yanhong Liu, Congcong Xiao, Chenfei Liu, Liqing Chen, Mingji Jin, Zhonggao Gao, Youyan Guan, Wei Huang.  (2023)  Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells.  Pharmaceutics,  15  (7): (1874).  [PMID:37514059]
25. Shuncheng Yao, Shaobo Wang, Minjia Zheng, Zhuo Wang, Zhirong Liu, Zhong Lin Wang, Linlin Li.  (2023)  Implantable, Biodegradable, and Wireless Triboelectric Devices for Cancer Therapy Through Disrupting Microtubule and Actins Dynamics.  ADVANCED MATERIALS,    (2303962).  [PMID:37392034]
26. Deqian Qiao, Yiling Liu, Yunlong Lei, Chundong Zhang, Youquan Bu, Yishu Tang, Ying Zhang.  (2023)  rRNA-Derived Small RNA rsRNA-28S Regulates the Chemoresistance of Prostate Cancer Cells by Targeting PTGIS.  Frontiers in Bioscience-Landmark,  28  (5): (102).  [PMID:37258478]
27. Qi Wenxia, Wang Shenglan, Yang Heng, Luo Tingting, Zhao Feng, Han Jingtian, Zhang Jing.  (2023)  An albumin-based nanosystem for cocktail therapy of breast cancer amplifies the therapeutic efficacy of combination chemotherapy with photodynamic therapy.  JOURNAL OF MATERIALS SCIENCE,  58  (21): (8952-8968).  [PMID:]
28. Xinran Wang, Jieyi Pan, Haohui Shi, Na Liang, Shaoping Sun.  (2023)  Biotin-modified acid-sensitive micelles for enhancing antitumor effect of paclitaxel.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  84  (104538).  [PMID:]
29. Pingfu Huang, Hui Yan, Hao Wu, Lulu Liu, Wenmin Niu, Bo Zhai, Ziwei Hu, Jingjuan Li, Qianming Du, Yang Zhou.  (2023)  Application of curcumin as a co-former and an efflux inhibitor in paclitaxel co-amorphous mixture.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  84  (104513).  [PMID:]
30. Feng Gao, Xinmin Zhao, Qiankang Si, Xingkun Niu, Shaojie Hou, Shihao Liu, Jun Guo, Liping Wang, Feng Zhang.  (2023)  Gemini surfactant-like peptide-based nanocages with β-sheet-enhanced stability and encapsulation efficiency of hydrophobic anticancer drugs.  RSC Advances,  13  (19): (12863-12868).  [PMID:37114030]
31. Changhai Wang, Yuwen Jiao, Xinyu Zhang, Mingxue Guo, Qing Zhang, Wenjun Hu, Shuang Dong, Tangthianchaichana Jakkree, Yang Lu, Jinling Wang.  (2023)  A paclitaxel prodrug nanoparticles with glutathion/reactive oxygen species dual-responsive and CD206 targeting to improve the anti-tumour effect.  IET Nanobiotechnology,  17  (5): (406-419).  [PMID:37055350]
32. Chunjing Guo, Wei Zhang, Qiaoyun Zhang, Yanguo Su, Xiaoya Hou, Qiang Chen, Huimin Guo, Ming Kong, Daquan Chen.  (2023)  Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer.  Artificial Cells Nanomedicine and Biotechnology,  51  (1): (170-179).  [PMID:37014123]
33. Jingshuai Wang, Xuemin Gu, Yiqin Ouyang, Lei Chu, Mengjiao Xu, Kun Wang, Xiaowen Tong.  (2023)  Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor Therapy.  International Journal of Nanomedicine,      [PMID:33623381]
34. Yaqin Tu, Wei Zhang, Guorun Fan, Chenming Zou, Jie Zhang, Nan Wu, Jiahui Ding, Wen Qing Zou, Hongjun Xiao, Songwei Tan.  (2023)  Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy.  DRUG DELIVERY,  30  (1): (2189106).  [PMID:36916054]
35. Zhou LiPing, Li JiaWei, Yu Bing, Zhang Jun, Hu Hao, Cong HaiLin, Shen YouQing.  (2023)  The drug loading behavior of PAMAM dendrimer: Insights from experimental and simulation study.  Science China-Technological Sciences,  66  (4): (1129-1140).  [PMID:]
36. Asmaa S.A. Hammad, Mohamed M. Sayed-Ahmed, Sara Mohamed Naguib Abdel Hafez, Ahmed R.N. Ibrahim, Mohamed M.A. Khalifa, Mahmoud El-Daly.  (2023)  Trimetazidine alleviates paclitaxel-induced peripheral neuropathy through modulation of TLR4/p38/NF-κB and klotho protein expression.  CHEMICO-BIOLOGICAL INTERACTIONS,  376  (110446).  [PMID:36898573]
37. Liu Fei, Xu Yanjun, Wang Li, Ma Xifeng, Zhang Zhen, Zhuang Xiaomei.  (2023)  Combined contributions of cytochrome P450s (CYPs) and non-enzymatic metabolism in the in vitro biotransformation of anaprazole, a novel proton pump inhibitor.  NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY,  396  (8): (1759-1771).  [PMID:36847804]
38. Yanzhao Jin, Jiaqing Cao, Hua Cheng, Xiaoyun Hu.  (2023)  LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.  JOURNAL OF CHEMOTHERAPY,      [PMID:36797828]
39. Wenquan Huang, Zhiqiang Li, Weiqi Liu, Shiyuan Liu, Rujin Zhou, Yanbin Jiang.  (2023)  Preparation of B16 cancer cell membrane coated α-zein biomimetic drug delivery system for the enhancement of homotypic target ability.  INDUSTRIAL CROPS AND PRODUCTS,  194  (116301).  [PMID:]
40. Chen Cheng, Weixi Jiang, Yuanli Luo, Li Wan, Xun Guo, Zhuoyan Xie, Rui Tang, Tong Huang, Jingxue Wang, Chier Du, Zhigang Wang, Haitao Ran, Pan Li, Zhiyi Zhou, Jianli Ren.  (2023)  NIR Activated Multimodal Therapeutics Based on Metal–Phenolic Networks-Functionalized Nanoplatform for Combating against Multidrug Resistance and Metastasis.  Small,  19  (14): (2206174).  [PMID:36651135]
41. Liang Chen, Yi Xu.  (2023)  Low temperature upregulating HSP70 expression to mitigate the paclitaxel-induced damages in NHEK cell.  PeerJ,  11  (e14630).  [PMID:36684674]
42. Xun Guo, Peng Tu, Leilei Zhu, Chen Cheng, Weixi Jiang, Chier Du, Xiaoting Wang, Xiaoling Qiu, Yuanli Luo, Li Wan, Rui Tang, Haitao Ran, Zhigang Wang, Jianli Ren.  (2023)  Nanoenabled Tumor Energy Metabolism Disorder via Sonodynamic Therapy for Multidrug Resistance Reversal and Metastasis Inhibition.  ACS Applied Materials & Interfaces,  15  (1): (309–326).  [PMID:36576435]
43. Li Huang, Huaqiang Fang, Teng Zhang, Binbin Hu, Shichen Liu, Fanzhen Lv, Zhaoxia Zeng, Huijie Liu, Weimin Zhou, Xiaolei Wang.  (2023)  Drug-loaded balloon with built-in NIR controlled tip-separable microneedles for long-effective arteriosclerosis treatment.  Bioactive Materials,  23  (526).  [PMID:36514389]
44. Lianzhen Li, Ziqiang Shang, Jianfu Tang, Jiameng Li, Zefang Xiao, Yanjun Xie, Jiuqing Liu, Zhenjie Li, Shilong Yang, Yiqi Liu, Wentao Gan.  (2022)  Wood Robot with Magnetic Anisotropy for Programmable Locomotion.  ADVANCED FUNCTIONAL MATERIALS,  33  (6): (2207209).  [PMID:]
45. Tong Gao, Xiao Sang, Xinyan Huang, Panpan Gu, Jie Liu, Yongjun Liu, Na Zhang.  (2022)  Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer.  Acta Pharmaceutica Sinica B,      [PMID:37799382]
46. Hong Liu, Zhenfu Wen, Haolin Chen, Zeyu Yang, Zhicheng Le, Zhijia Liu, Yongming Chen, Lixin Liu.  (2022)  Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels.  JOURNAL OF CONTROLLED RELEASE,  352  (497).  [PMID:36341931]
47. Jiayin Liu, Yang An, Jun Su, Qinghai Dong, Hongliu Xie, Jihua Liu.  (2022)  The antitumor activity and pharmacokinetics research of PPD-Arg (Tos) using ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.  BIOMEDICAL CHROMATOGRAPHY,  37  (2): (e5535).  [PMID:36289571]
48. ChengYu Deng, Rong Zhuang, ZhuoYang Ying, Jiasheng Tu, Xianghui Xu, Chunmeng Sun, Lei Jiang.  (2022)  Non-Invasive Transdermal Delivery Systems with Deep Tissue Penetrating Ability for Local ROS-Modulating Chemotherapy.  ADVANCED FUNCTIONAL MATERIALS,  32  (46): (2206876).  [PMID:]
49. Xueting Tang, Lin Chen, Ziyu Wu, Yazhou Li, Jiaqi Zeng, Wentao Jiang, Wenzhi Lv, Mimi Wan, Chun Mao, Min Zhou.  (2022)  Lipophilic NO-Driven Nanomotors as Drug Balloon Coating for the Treatment of Atherosclerosis.  Small,  19  (13): (2203238).  [PMID:35961946]
50. Tianyu Chen, Hui Chen, Yichun Jiang, Qi Yan, Shuling Zheng, Min Wu.  (2022)  Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment.  Pharmaceuticals,  15  (7): (881).  [PMID:35890181]
51. Chunyan Yang, Zhongzhen Yang, Siqi Wang, Jinxia Chen, Qijun Liu, Tianle Huang, Li Hai, Runxin Lu, Yong Wu.  (2022)  Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.  BIOORGANIC & MEDICINAL CHEMISTRY,  69  (116893).  [PMID:35752143]
52. Chenglong Wang, Xiaolin Xu, Shuhan Xiong, Peipei Zhang, Jia Yuan, Xuzhu Gao, Wencai Guan, Fanchen Wang, Xin Li, Tao Leng, Hongjing Dou, Guoxiong Xu.  (2022)  Calcium-chelated nanosystem reversing cancer chemoresistance via replenishing intracellular calcium ions.  CHEMICAL ENGINEERING JOURNAL,  448  (137500).  [PMID:]
53. Xiaowei Wang, Yanhong Liu, Yue Hu, Hong Gao, Meiling Ge, Jie Ding, Dongkai Wang.  (2022)  Hybrid micelles loaded with chemotherapeutic drug-photothermal agent realizing chemo-photothermal synergistic cancer therapy.  EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,  175  (106231).  [PMID:35671901]
54. Yi Peng, Jie Pan, Fengting Ou, Wenchao Wang, Haihong Hu, Lu Chen, Su Zeng, Kui Zeng, Lushan Yu.  (2022)  Fenbendazole and its synthetic analog interfere with HeLa cells’ proliferation and energy metabolism via inducing oxidative stress and modulating MEK3/6-p38-MAPK pathway.  CHEMICO-BIOLOGICAL INTERACTIONS,  361  (109983).  [PMID:35569513]
55. Xiao-Ling Wang, Wen-Zheng Zhao, Jia-Ze Fan, Le-Chen Jia, Ya-Nan Lu, Ling-Hui Zeng, Yuan-Yuan Lv, Xiao-Yi Sun.  (2022)  Tumor Tropic Delivery of Hyaluronic Acid-Poly (D,L-lactide-co-glycolide) Polymeric Micelles Using Mesenchymal Stem Cells for Glioma Therapy.  MOLECULES,  27  (8): (2419).  [PMID:35458619]
56. Mingming Song, Shuqi Dong, Xiaofei An, Wenxiang Zhang, Ning Shen, Yanbo Li, Caixia Guo, Chang Liu, Xiao Li, Siyu Chen.  (2022)  Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.  JOURNAL OF CONTROLLED RELEASE,  345  (744).  [PMID:35381274]
57. Yan Du, Li Lin, Zhong Zhang, Yu Tang, Xia Ou, Yaotai Wang, Jianzhong Zou.  (2022)  Drug-loaded nanoparticles conjugated with genetically engineered bacteria for cancer therapy.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,  606  (29).  [PMID:35338856]
58. Huiru Zhu, Li Kong, Xu Zhu, Tingting Ran, Xiaojuan Ji.  (2022)  pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis.  Pharmaceutics,  14  (3): (535).  [PMID:35335910]
59. Beibei Zhang, Rui Xue, Chunyang Sun.  (2022)  Rational design of ROS-responsive nanocarriers for targeted X-ray-induced photodynamic therapy and cascaded chemotherapy of intracranial glioblastoma.  Nanoscale,  14  (13): (5054-5067).  [PMID:35293920]
60. Xinling Xie, Youquan Zhang, Yong Zhu, Yiling Lan.  (2022)  Preparation and Drug-Loading Properties of Amphoteric Cassava Starch Nanoparticles.  Nanomaterials,  12  (4): (598).  [PMID:35214927]
61. Chunjing Guo, Yanguo Su, Ziting Cheng, Qiang Chen, Huimin Guo, Ming Kong, Daquan Chen.  (2022)  Novel ROS-responsive marine biomaterial fucoidan nanocarriers with AIE effect and chemodynamic therapy.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,  202  (112).  [PMID:35041879]
62. Hao Li, Wenbo Xie, Lei Zeng, Wen Li, Boan Shi, Fuhou Lei.  (2022)  Development and evaluation of a hydrogenated rosin (β-acryloxyl ethyl) ester–bonded silica stationary phase for high-performance liquid chromatography separation of paclitaxel from yew bark.  JOURNAL OF CHROMATOGRAPHY A,  1665  (462815).  [PMID:35038614]
63. Yangming-Fan, Jianjun-Ge.  (2022)  Pentoxifylline Prevents Restenosis by Inhibiting Cell Proliferation via p38MAPK Pathway in Rat Vein Graft Model..  CELL TRANSPLANTATION,  31  (9636897221122999-9636897221122999).  [PMID:36066039]
64. Haiqin Huang, Lanlan Shao, Yan Chen, Lan Tang, Tianqing Liu, Junxu Li, Hongyan Zhu.  (2021)  Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes−liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer.  Bioengineering & Translational Medicine,  (2): (e10284).  [PMID:35600651]
65. Sushan Ouyang, Yi Zhang, Sheng Yao, Longbao Feng, Ping Li, Senlin Zhu.  (2021)  The efficiency of MSC-based targeted AIE nanoparticles for gastric cancer diagnosis and treatment: An experimental study.  Bioengineering & Translational Medicine,  (2): (e10278).  [PMID:35600644]
66. Huan Zhang, Jinshun Xu, Binyang Gao, Hong Wang, Jianbo Huang, Jie Zhou, Rui Yang, Feng Yan, Yulan Peng.  (2021)  Synergistic Cascade Strategy Based on Modifying Tumor Microenvironment for Enhanced Breast Cancer Therapy.  Frontiers in Pharmacology,  12  (750847).  [PMID:34867360]
67. Yuqiong Shi, Wei Liu, Xiangrong Wu, Jinhua Zhu, Danyang Zhou, Xiuhua Liu.  (2021)  A Water-Soluble Polyacid Polymer Based on Hydrophilic Metal–Organic Frameworks Using Amphoteric Carboxylic Acid Ligands as Linkers for Hydroxycamptothecin Loading and Release In Vitro.  Nanomaterials,  11  (11): (2854).  [PMID:34835619]
68. Tian Chai, Yin Qiang.  (2022)  Two new coumarins from branches of Zanthoxylum schinifolium.  JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH,  24  (9): (820-826).  [PMID:34662216]
69. Rui Zhang, Ge Cheng, Shengnan Liu, Hongying Lv, Juan Li.  (2021)  A four-in-one pure nanomedicine for synergistic multi-target therapy against breast cancer.  Journal of Materials Chemistry B,  (42): (8809-8822).  [PMID:34633023]
70. Yadong Tang,Boxin Huang,Yuqin Dong,Wenlong Wang,Xi Zheng,Wei Zhou,Kun Zhang,Zhiyun Du.  (2017-06-07)  Three-dimensional prostate tumor model based on a hyaluronic acid-alginate hydrogel for evaluation of anti-cancer drug efficacy..  Journal of biomaterials science. Polymer edition,  28  ((14)): (1603-1616).  [PMID:28583017]
71. Lingling Wang,Xiuhua Zhao,Fengjian Yang,Weiwei Wu,Mingfang Wu,Yuanyuan Li,Xiaoxue Zhang.  (2019-07-16)  Loading paclitaxel into porous starch in the form of nanoparticles to improve its dissolution and bioavailability..  International journal of biological macromolecules,  138  (207-214).  [PMID:31306708]
72. Wanbing Qin,Guilan Quan,Ying Sun,Minglong Chen,Peipei Yang,Disang Feng,Ting Wen,Xinyu Hu,Xin Pan,Chuanbin Wu.  (2020-07-30)  Dissolving Microneedles with Spatiotemporally controlled pulsatile release Nanosystem for Synergistic Chemo-photothermal Therapy of Melanoma..  Theranostics,  10  ((18)): (8179-8196).  [PMID:32724465]
73. Xuejing Zhang,Shiwei Niu,Gareth R Williams,Jianrong Wu,Xia Chen,Hong Zheng,Li-Min Zhu.  (2019-06-23)  Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy..  Carbohydrate polymers,  221  (84-93).  [PMID:31227170]
74. Li FF, Sun Q, Wang D, Liu S, Lin B, Liu CT, Li LZ, Huang XX, Song SJ..  (2016)  Chiral Separation of Cytotoxic Flavan Derivatives from Daphne giraldii..  J Nat Prod,  79  (9): (2236-2242).  [PMID:27627130]

Solution Calculators